SEEL logo

Seelos Therapeutics (SEEL) Long Term Debt

Annual Long Term Debt

$0.00
-$8.20 M-100.00%

31 December 2023

SEEL Long Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Long Term Debt

N/A

30 June 2024

SEEL Quarterly Long Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SEEL Long Term Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-100.0%-
3 y3 years-100.0%-
5 y5 years--

SEEL Long Term Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-100.0%
5 y5 years-100.0%
alltimeall time-100.0%

Seelos Therapeutics Long Term Debt History

DateAnnualQuarterly
Dec 2023
$0.00(-100.0%)
$0.00(-100.0%)
Sept 2023
-
$1.30 M(-55.9%)
June 2023
-
$2.96 M(-42.0%)
Mar 2023
-
$5.10 M(-37.8%)
Dec 2022
$8.20 M(-54.2%)
$8.20 M(-23.7%)
Sept 2022
-
$10.74 M(-9.1%)
June 2022
-
$11.81 M(-20.9%)
Mar 2022
-
$14.93 M(-16.6%)
Dec 2021
$17.89 M(+145.3%)
$17.89 M(>+9900.0%)
June 2021
-
$16.00 K(-99.5%)
Mar 2021
-
$3.27 M(-55.1%)
Dec 2020
$7.29 M(+57.7%)
$7.29 M(+4861.2%)
Sept 2020
-
$147.00 K(0.0%)
June 2020
-
$147.00 K(-98.0%)
Sept 2015
-
$7.19 M(+81.9%)
June 2015
-
$3.95 M(-7.9%)
Mar 2015
-
$4.29 M(-7.2%)
Dec 2014
$4.63 M(+35.5%)
$4.63 M(+319.8%)
Sept 2013
-
$1.10 M(+2.5%)
June 2013
-
$1.07 M(-68.3%)
Mar 2013
-
$3.39 M(-0.6%)
Dec 2012
$3.41 M(-16.8%)
$3.41 M(-14.7%)
Sept 2011
-
$4.00 M(0.0%)
June 2011
-
$4.00 M(-2.4%)
Mar 2011
-
$4.10 M(-0.0%)
Dec 2010
$4.10 M
$4.10 M(+0.2%)
Sept 2010
-
$4.09 M(-0.2%)
June 2010
-
$4.10 M(-0.2%)
DateAnnualQuarterly
Mar 2010
-
$4.11 M(+32.3%)
Dec 2009
$3.10 M(-33.8%)
$3.10 M(-13.5%)
Sept 2009
-
$3.59 M(-17.3%)
June 2009
-
$4.34 M(-7.5%)
Mar 2009
-
$4.69 M(0.0%)
Dec 2008
$4.69 M(+84.7%)
$4.69 M(-1.3%)
Sept 2008
-
$4.75 M(0.0%)
June 2008
-
$4.75 M(+81.6%)
Mar 2008
-
$2.62 M(+3.0%)
Dec 2007
$2.54 M(-15.4%)
$2.54 M(-15.4%)
Mar 2006
-
$3.00 M(0.0%)
Dec 2005
$3.00 M(-51.9%)
$3.00 M(-50.2%)
Sept 2005
-
$6.02 M(-0.7%)
June 2005
-
$6.06 M(-1.1%)
Mar 2005
-
$6.13 M(-1.7%)
Dec 2004
$6.23 M(-9.4%)
$6.23 M(-2.2%)
Sept 2004
-
$6.38 M(-2.3%)
June 2004
-
$6.53 M(-2.4%)
Mar 2004
-
$6.69 M(-2.7%)
Dec 2003
$6.88 M(+26.6%)
$6.88 M(+204.5%)
Sept 2003
-
$2.26 M(-28.5%)
June 2003
-
$3.16 M(-22.5%)
Mar 2003
-
$4.08 M(-24.9%)
Dec 2002
$5.43 M(+649.7%)
$5.43 M(+3.2%)
Sept 2002
-
$5.26 M(+3.6%)
June 2002
-
$5.08 M(+683.7%)
Mar 2002
-
$648.20 K(-10.5%)
Dec 2001
$724.60 K
$724.60 K(+19.9%)
Sept 2001
-
$604.10 K

FAQ

  • What is Seelos Therapeutics annual long term debt?
  • What is the all time high annual long term debt for Seelos Therapeutics?
  • What is Seelos Therapeutics annual long term debt year-on-year change?
  • What is the all time high quarterly long term debt for Seelos Therapeutics?

What is Seelos Therapeutics annual long term debt?

The current annual long term debt of SEEL is $0.00

What is the all time high annual long term debt for Seelos Therapeutics?

Seelos Therapeutics all-time high annual long term debt is $17.89 M

What is Seelos Therapeutics annual long term debt year-on-year change?

Over the past year, SEEL annual long term debt has changed by -$8.20 M (-100.00%)

What is the all time high quarterly long term debt for Seelos Therapeutics?

Seelos Therapeutics all-time high quarterly long term debt is $17.89 M